CVS Health (CVS) Form 4: EVP reports trust buys at $56.47–$62.24

CVS Health reported insider transactions by its EVP and Chief People Officer.

Accepted by SEC EDGAR 10/14/2025 - 07:08 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

CVS Health reported insider transactions by its EVP and Chief People Officer. The filing shows indirect purchases of common stock held by a trust for the benefit of the officer’s spouse. Reported trades: 35 shares at $56.47 on 09/09/2024, 10 shares at $62.24 on 10/02/2024, and 35 shares at $56.85 on 10/23/2024. The explanation notes the shares were bought at a broker’s discretion for a managed account and were not previously reported due to a broker error.

Insider Trade Summary

Net Buyer: 80 shares

Net Buy 3 txns

Insider CAPOZZI HEIDI B

Role EVP and Chief People Officer

Bought 80 shs ($5K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	35	$56.85	$2K
Purchase	Common Stock	10	$62.24	$622.40
Purchase	Common Stock	35	$56.47	$2K

Holdings After Transaction: Common Stock — 85 shares (Indirect, By Trust)

Holdings Before and After: Common Stock, 5 to 85 shares (Indirect, By Trust)

Footnotes (1)

1. F1. Shares purchased by a broker exercising discretion for a managed account in the name of a trust for the benefit of the Reporting Person's spouse that were not previously reported due to an error on the part of the broker.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CVS (CVS) disclose in this Form 4?

Indirect purchases of CVS common stock by a trust for the benefit of the officer’s spouse, reported by the company’s EVP and Chief People Officer.

What were the share amounts and prices reported?

Trades reported: 35 shares at $56.47 (09/09/2024), 10 shares at $62.24 (10/02/2024), and 35 shares at $56.85 (10/23/2024).

How is ownership classified in the filing?

Ownership is listed as Indirect (I) with the nature described as By Trust.

Who is the reporting person’s role at CVS?

The reporting person is an Officer, serving as EVP and Chief People Officer.

Why were these trades disclosed now?

The note states shares were purchased at a broker’s discretion for a managed account and were not previously reported due to a broker error.

What were the share balances after each trade?

Reported beneficial holdings (indirect) were 40, 50, and 85 shares following the respective transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

CAPOZZI HEIDI B

(Last) (First) (Middle)

ONE CVS DRIVE

(Street)

WOONSOCKET RI 02895

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CVS HEALTH Corp [ CVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and Chief People Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2024

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2024		P(1)		35	A	$56.47	40	I	By Trust
Common Stock	10/02/2024		P(1)		10	A	$62.24	50	I	By Trust
Common Stock	10/23/2024		P(1)		35	A	$56.85	85	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares purchased by a broker exercising discretion for a managed account in the name of a trust for the benefit of the Reporting Person's spouse that were not previously reported due to an error on the part of the broker.

	/s/ Heidi B. Capozzi	10/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.